Should You Invest in the iShares U.S. Healthcare ETF (IYH)?

Core Insights - The iShares U.S. Healthcare ETF (IYH) is a passively managed ETF launched on June 12, 2000, designed to provide broad exposure to the Healthcare - Broad segment of the equity market [1] - The ETF has accumulated over $2.74 billion in assets, making it one of the larger ETFs in its category [3] - The fund has an annual operating expense ratio of 0.39% and a 12-month trailing dividend yield of 1.38% [4] Fund Details - IYH aims to match the performance of the Dow Jones U.S. Health Care Index before fees and expenses [3] - The ETF has a beta of 0.63 and a standard deviation of 14.2% over the trailing three-year period, indicating a medium risk profile [7] - The ETF's top holdings include Eli Lilly (12.28%), Johnson & Johnson, and Abbvie Inc, with the top 10 holdings accounting for approximately 53.42% of total assets [5][6] Performance Metrics - Year-to-date, IYH has lost about 4.51% and is down approximately 11.01% over the last 12 months as of August 13, 2025 [7] - The ETF has traded between $53.97 and $66.38 in the past 52 weeks [7] Alternatives - Other ETFs in the healthcare sector include Vanguard Health Care ETF (VHT) with $14.81 billion in assets and Health Care Select Sector SPDR ETF (XLV) with $31.99 billion in assets [9] - VHT has an expense ratio of 0.09% and XLV charges 0.08% [9] Investment Considerations - IYH carries a Zacks ETF Rank of 3 (Hold), indicating it is a reasonable option for investors seeking exposure to the healthcare sector [8]